Schiff based injectable hydrogel for in situ pH-triggered delivery of doxorubicin for breast tumor treatment
Schiff based injectable hydrogel for in situ pH-triggered delivery of doxorubicin for breast tumor treatment
复制标题
基于希夫的可注射水凝胶,用于原位 pH 触发输送阿霉素,用于乳腺肿瘤治疗
DOI:
10.1039/c4py00631c
复制
发表时间:
2014
影响因子:
4.6
通讯作者:
Xing Malcolm M. Q.
中科院分区:
文献类型:
--
作者:
Shi Junbin;Guobao Wang;Chen Hongli;Zhong Wen;Qiu Xiaozhong;Xing Malcolm M. Q.
In this study, we report a facile approach to develop an injectable hydrogel with an in situ and pH sensitive drug delivery system for cancer treatment. The hydrogel was based on modified chitosan and alginate. We conjugated doxorubicin (DOX) to succinated chitosan (S-chi) via a Schiff base between a ketone group in the DOX and an amine group in the S-chi, which led to a pH sensitive release of DOX upon the stimulus of an acidic tumor microenvironment. Hydrogel formed in minutes while DOX conjugated S-chi was mixed with oxidized alginate. The hydrogel structure was characterized by cryo-imaging, FTIR and a rheology test. The DOX release profiles were tested in response to different pH values. The MTT assay showed a low toxicity of the hydrogel. The gel in turn inhibited the growth of tumor cells MCF-7 effectively when loaded with DOX. Finally, the DOX laden hydrogel was injected into the xenograft breast tumor model and significantly inhibited tumor growth.